Pacira BioSciences, Inc. (PCRX) earnings per share (EPS)
Pacira BioSciences, Inc. (PCRX) reported diluted earnings per share of $0.16 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.15. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Earnings per share, fiscal 2025
- $0.16
- Growth, 5 years
- −45.5% a year
- Growth, 10 years
- +14.9% a year
- Highest on record
- $3.33fiscal 2020
- Lowest on record
- -$2.15fiscal 2024
- Fiscal years on record
- 132013–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Pacira BioSciences, Inc. earnings per share (EPS), in more detail
Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 45.5% a year; over ten years the rate was 14.9% a year. Across the 13 fiscal years on record (2013–2025), the highest was $3.33 in fiscal 2020 and the lowest -$2.15 in fiscal 2024.
Earnings per share by fiscal year
Pacira BioSciences, Inc. earnings per share (EPS), year by year
| Fiscal year | Earnings per share | Change | Year ended |
|---|---|---|---|
| 2025 | $0.16 | — | |
| 2024 | -$2.15 | 341.6% down | |
| 2023 | $0.89 | 161.8% up | |
| 2022 | $0.34 | 63.0% down | |
| 2021 | $0.92 | 72.4% down | |
| 2020 | $3.33 | — | |
| 2019 | -$0.27 | — | |
| 2018 | -$0.01 | — | |
| 2017 | -$1.07 | — | |
| 2016 | -$1.02 | 2,650.0% down | |
| 2015 | $0.04 | — | |
| 2014 | -$0.39 | — | |
| 2013 | -$1.93 | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.
How to read it
It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.
Pacira BioSciences, Inc., figure by figure
- Pacira BioSciences, Inc. market cap
- Pacira BioSciences, Inc. revenue
- Pacira BioSciences, Inc. earnings
- Pacira BioSciences, Inc. P/E ratio
- Pacira BioSciences, Inc. P/S ratio
- Pacira BioSciences, Inc. P/B ratio
- Pacira BioSciences, Inc. free cash flow
- Pacira BioSciences, Inc. operating margin
- Pacira BioSciences, Inc. dividend
- Pacira BioSciences, Inc. shares outstanding
- Pacira BioSciences, Inc. total debt
- Pacira BioSciences, Inc. cash on hand
- Pacira BioSciences, Inc. total assets
- Pacira BioSciences, Inc. return on equity (ROE)
- Pacira BioSciences, Inc. return on invested capital (ROIC)
Pacira BioSciences, Inc. (PCRX) overview: price, valuation and scorecard
Pacira BioSciences, Inc. earnings per share (EPS): questions and answers
What is Pacira BioSciences, Inc.'s diluted earnings per share?
Pacira BioSciences, Inc. (PCRX) reported diluted earnings per share of $0.16 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.15.
What is the growth rate of Pacira BioSciences, Inc.'s diluted earnings per share?
Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 45.5% a year; over ten years the rate was 14.9% a year.
What are the highest and lowest diluted earnings per share figures on record for Pacira BioSciences, Inc.?
Across the 13 fiscal years on record (2013–2025), the highest was $3.33 in fiscal 2020 and the lowest -$2.15 in fiscal 2024.
How is Pacira BioSciences, Inc.'s diluted earnings per share calculated?
Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits. For Pacira BioSciences, Inc. it is on record here for 13 fiscal years, 2013 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: earnings per share (EPS)
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Pacira BioSciences, Inc. (PCRX) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/PCRX/eps
Underlying data: the company's filings with the SEC and Yahoo Finance.